People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,555.50GBp
24 Dec 2014
Price Change (% chg)

39.00p (+0.86%)
Prev Close
4,516.50p
Open
4,542.00p
Day's High
4,573.00p
Day's Low
4,526.00p
Volume
403,816
Avg. Vol
2,570,353
52-wk High
4,946.41p
52-wk Low
3,367.07p

Search Stocks

Hudson, Paul 

Brief Biography

Mr. Paul Hudson is the Executive Vice President, North America of AstraZeneca PLC., since January 2013 and leads AstraZeneca’s commercial operations in North America. In this capacity, he is accountable for driving growth and maximising the contribution of North America to AstraZeneca’s global business. Paul joined AstraZeneca in 2006 as Vice-President and Primary Care Director, UK. Paul’s most recent role with AstraZeneca was President of AstraZeneca’s Japanese business. He has served as a Standing Board Member of Japan Pharmaceuticals Manufacturers Association and EFPIA in Japan. Previously, Paul was President of AstraZeneca’s business in Spain. Before AstraZeneca, Paul worked for Schering-Plough, where he held senior global marketing roles. Paul received a degree in economics from Manchester Metropolitan University and a DipM from the UK’s Chartered Institute of Marketing.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leif Johansson

540,000

Pascal Soriot

3,344,000

Marc Dunoyer

296,000

Ruud Dobber

--

Caroline Hempstead

--

Paul Hudson

--
As Of 30 Dec 2013
Search Stocks